{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:43:24Z","timestamp":1791179004823,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1007\/s11908-999-0046-y","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T23:14:49Z","timestamp":1180048489000},"page":"384-388","source":"Crossref","is-referenced-by-count":12,"title":["Antibiotic selection for urinary tract infection: New microbiologic considerations"],"prefix":"10.1007","volume":"1","author":[{"given":"Patricia D.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"46_CR1","volume-title":"Urinary Tract Infections: Detection, Prevention, and Management","author":"CM Kunin","year":"1997","unstructured":"Kunin CM: Urinary Tract Infections: Detection, Prevention, and Management. Baltimore: Williams and Wilkins; 1997."},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM199310283291808","volume":"329","author":"WE Stamm","year":"1993","unstructured":"Stamm WE, Hooton TM: Management of urinary tract infections in adults. N Engl J Med 1993, 329:1328\u20131334.","journal-title":"N Engl J Med"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","volume":"335","author":"TM Hooton","year":"1996","unstructured":"Hooton TM, Scholes D, Hughes JP, et al.: A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996, 335:468.","journal-title":"N Engl J Med"},{"key":"46_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/18.1.1","volume":"18","author":"CM Kunin","year":"1994","unstructured":"Kunin CM: Urinary tract infections in females. Clin Infect Dis 1994, 18:1\u201312.","journal-title":"Clin Infect Dis"},{"key":"46_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00019048-199507000-00001","volume":"4","author":"MF Falagas","year":"1995","unstructured":"Falagas MF, Gorbach SL: Practice guidelines: urinary tract infection. Infect Dis Clin Pract 1995, 4:241\u2013257.","journal-title":"Infect Dis Clin Pract"},{"key":"46_CR6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0891-5520(05)70373-1","volume":"11","author":"TM Hooton","year":"1997","unstructured":"Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infections. Infect Dis Clin North Am 1997, 11:551\u2013581.","journal-title":"Infect Dis Clin North Am"},{"key":"46_CR7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bmj.317.7159.654","volume":"317","author":"H Goossm","year":"1998","unstructured":"Goossm H, Spranger MJW: Community acquired infections and bacterial resistance. BMJ 1998, 317:654\u2013657.","journal-title":"BMJ"},{"key":"46_CR8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.281.8.736","volume":"281","author":"K Gupta","year":"1999","unstructured":"Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999, 281:736\u2013738. These investigators report antimicrobial susceptibility patterns among uropathogens isolated from women with acute uncomplicated cystitis from 1992 through 1996. A significant increase in resistance among E. coli and all isolates to firstline antimicrobial agents was observed. Although the authors suggest that a change in firstline therapy should be considered in areas where this type of resistance is increasing, data are currently lacking regarding the impact of in vitro resistance on clinical response in acute cystitis.","journal-title":"JAMA"},{"key":"46_CR9","first-page":"265","volume":"169","author":"IE Dyer","year":"1998","unstructured":"Dyer IE, Sankary TM, Dawson JA: Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West J Med 1998, 169:265\u2013268. This study reports trends in antimicrobial resistance among urinary tract isolates of E. coli from 1991 through 1997. Increasing resistance to firstline agents was seen, similar to the study by Gupta et al. [8\u2022\u2022], whereas no resistance to nitrofurantoin was observed.","journal-title":"West J Med"},{"key":"46_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0732-8893(98)00113-8","volume":"32","author":"M Cormican","year":"1998","unstructured":"Cormican M, Morris D, Corbett-Teeney G, Flynn J: Extended spectrum beta-lactamase production and fluoroquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn Microbiol Infect Dis 1998, 32:317\u2013319.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"46_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/17843286.1998.11754161","volume":"53","author":"TH Christiaens","year":"1998","unstructured":"Christiaens TH, Heytens S, Verschragen G, et al.: Which bacteria are found in Belgian women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95\u201396. Acta Clin Belg 1998, 53:184\u2013188.","journal-title":"Acta Clin Belg"},{"issue":"suppl 1","key":"46_CR12","first-page":"567","volume":"24","author":"JF Acar","year":"1997","unstructured":"Acar JF, Goldstein FW: Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997, 24(suppl 1):567\u2013573. This is an informative review of the worldwide emergence of fluoroquinolone resistance among bacteria, including uropathogens.","journal-title":"Clin Infect Dis"},{"key":"46_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7883\/yoken1952.50.241","volume":"50","author":"J Iqbal","year":"1997","unstructured":"Iqbal J, Rahman M, Kabir MS, Rahman M: Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh. Jpn J Med Sci Biol 1997, 50:241\u2013250.","journal-title":"Jpn J Med Sci Biol"},{"issue":"suppl 1","key":"46_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000048461","volume":"44","author":"JA Garcia-Rodriguez","year":"1998","unstructured":"Garcia-Rodriguez JA: Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infections in Spain. Chemotherapy 1998, 44(suppl 1):28\u201330.","journal-title":"Chemotherapy"},{"key":"46_CR15","first-page":"1436","volume":"160","author":"UD Allen","year":"1999","unstructured":"Allen UD, MacDonald N, Fuite L, et al.: Risk factors for resistance to ldfirst-line\" antimicrobials among urinary tract isolates of Escherichia coli in children. Can Med Assoc J 1999, 160:1436\u20131440.","journal-title":"Can Med Assoc J"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/030006059602400310","volume":"24","author":"F Jinnah","year":"1996","unstructured":"Jinnah F, Islam MS, Rumi MAK, et al.: Drug sensitivity pattern of E. coli causing urinary tract infection in diabetic and non-diabetic patients. J Int Med Res 1996, 24:296\u2013301.","journal-title":"J Int Med Res"},{"key":"46_CR17","first-page":"789","volume-title":"Antimicrobial Therapy and Vaccines","author":"GE Stein","year":"1999","unstructured":"Stein GE, Havlichek DH: Fosfomycin. In Antimicrobial Therapy and Vaccines. Edited by Yu VL, Meriginn TL, Barriere SL, et al. Baltimore: Williams and Wilkins; 1999:789\u2013794."},{"key":"46_CR18","first-page":"104","volume":"44","author":"GE Stein","year":"1999","unstructured":"Stein GE: Fosfomycin tromethamine: single-dose treatment of acute cystitis. Int J Fertil 1999, 44:104\u2013109. This is a helpful, concise review of a relatively newer agent for the management of uncomplicated cystitis.","journal-title":"Int J Fertil"},{"key":"46_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/40.4.591","volume":"40","author":"PL Fuchs","year":"1997","unstructured":"Fuchs PL, Barry AL, Brown SD: Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American Medical Centres by three methods. J Antimicrob Chemother 1997, 40:591\u2013594.","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 14","key":"46_CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF01710019","volume":"20","author":"D Greenwood","year":"1992","unstructured":"Greenwood D, Edwards R, Brown J, et al.: The comparative activity of fosfomycin tromethamine against organisms isolated from infected urines. Infection 1992, 20(suppl 14):302\u2013304.","journal-title":"Infection"},{"key":"46_CR21","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1086\/520283","volume":"26","author":"RL Moellering","year":"1998","unstructured":"Moellering RL:Vancomycin-resistant enterococci. Clin Infect Dis 1998, 26:1196\u20131199.","journal-title":"Clin Infect Dis"},{"key":"46_CR22","first-page":"846","volume-title":"Antimicrobial Therapy and Vaccines","author":"GE Stein","year":"1999","unstructured":"Stein GE, Havlichek DH: Nitrofurantoin. In Antimicrobial Therapy and Vaccines. Edited by Yu VL, Merigian TL, Barriere SL, et al. Baltimore: Williams and Wilkins; 1999:846\u2013850."},{"key":"46_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1995.03520250057034","volume":"273","author":"TM Hooton","year":"1995","unstructured":"Hooton TM, Winter C, Tiu F, Stamm WE: Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995, 273:41\u201345.","journal-title":"JAMA"},{"key":"46_CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/42.3.363","volume":"42","author":"W Brumfitt","year":"1998","unstructured":"Brumfitt W, Hamilton-Miller JMT: Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years experience. J Antimicrob Chemother 1998, 42:363\u2013371. The authors review their experience with three regimens of long-term prophylaxis with nitrofurantoin. Although some patients had to stop therapy because of side effects, severe toxicities were rare.","journal-title":"J Antimicrob Chemother"},{"key":"46_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2105\/AJPH.80.3.331","volume":"80","author":"B Foxman","year":"1990","unstructured":"Foxman B: Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990, 80:331\u2013333.","journal-title":"Am J Public Health"},{"key":"46_CR26","first-page":"719","volume":"11","author":"A Stapleton","year":"1997","unstructured":"Stapleton A, Stamm WE: Prevention of urinary tract infection. Med Clin North Am 1997, 11:719\u2013734.","journal-title":"Med Clin North Am"},{"key":"46_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/joc.1997.9.3.203","volume":"9","author":"F Mauromanolakis","year":"1997","unstructured":"Mauromanolakis F, Marek S, Samonis G, et al.: Effect of norfloxacin, trimethroprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother 1997, 9:203\u2013207.","journal-title":"J Chemother"},{"key":"46_CR28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(05)75468-4","volume":"353","author":"KG Kerr","year":"1999","unstructured":"Kerr KG: Cranberry juice and prevention of recurrent urinary tract infection. Lancet 1999, 353:673.","journal-title":"Lancet"},{"key":"46_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-128-4-199802150-00056","volume":"128","author":"DA Cramer","year":"1998","unstructured":"Cramer DA: Recurrent urinary tract infection: new theories and an old remedy. Ann Intern Med 1998, 128:333\u2013334.","journal-title":"Ann Intern Med"},{"issue":"(suppl 2)","key":"46_CR30","first-page":"502","volume":"18","author":"LE Nicolle","year":"1990","unstructured":"Nicolle LE: The optimal management of lower urinary tract infections. Infection 1990, 18(suppl 2):502.","journal-title":"Infection"},{"key":"46_CR31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(99)00122-9","volume":"106","author":"S Saint","year":"1999","unstructured":"Saint S, Schoeles D, Finn SD, et al.: The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med 1999, 106:636\u2013641.","journal-title":"Am J Med"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-999-0046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-999-0046-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-999-0046-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:24:22Z","timestamp":1559420662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-999-0046-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s11908-999-0046-y","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}